Quantrx Biomedical Corporation (Order to Show Cause)

The Securities and Exchange Commission initiated proceedings against Quantrx Biomedical Corporation under Section 12(j) of the Securities Exchange Act of 1934. The order to show cause, issued on December 10, 2024, requires Respondent to explain why its registration should not be revoked due to failure to file an answer or defend this proceeding by December 24, 2024. The main purpose of this action is to enforce compliance with the Securities Exchange Act of 1934.